BioTelemetry used to be called CardioNet. Its ticker symbol is BEAT.
BioTelemetry had an investor’s call this morning. They discussed the purchase of a company called LifeWatch. BEAT has had made a few other acquisitions the past few months.
BEAT makes wireless cardiac monitoring devices that help healthcare providers monitor patients’ health.
In the past 2 weeks, Amazon (AMZN) and Tesla (TSLA) have received multiple upgrades. This has helped propel their stock price higher.
BioTelemetry has only a few analysts covering it. As more analysts cover BEAT and assign price targets for the stock, the stock price should shoot up higher.
BEAT went public 2 years ago and it’s beaten earnings all 8 quarters. It beats EPS estimates by 40% on average and the stock usually goes up 8% after reporting earnings.
The stock is trading above its 50 and 200 Moving Day Average (MDA)
Technically it’s clear skies for BEAT until it hits $50. So it looks like BEAT will be playing a good tune for investors for the next couple of years.
» Subscribe to TwinsTalkStocks: http://bit.ly/SDTTS
About TwinsTalkStocks: Join 9 year old twins, Devin Kalel and Ashay Jorel, as they talk about the stock market. Whether you want to save up for college, buy a new car, make a down payment on a house, save up for a vacation, or just make some extra money to pay some bills, Twins Talk Stocks can help you!
Connect with TwinsTalkStocks Online